A Clinical Trial on the Antipsychotic Properties of Cannabidiol

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006

This article is included in 2 Systematic reviews Systematic reviews (2 references)

This article is part of the following publication threads:
This article is part of the following matrixes of evidence:
Loading references information
The purpose of this study is to determine whether cannabidiol, a herbal cannabinoid, is effective in the treatment of acute schizophrenic or schizophreniform psychosis in a placebo-controlled, randomized double-blind study.
Epistemonikos ID: d8123565f5b66cc39f7ee4c009a171082adda915
First added on: Jul 16, 2015